A:
The chronic use of opioid therapy to treat noncancer pain syndromes, such as headache and low - back pain, and arthritis, continues to be controversial.
Not exact matches
BUFFALO, N.Y. (WBEN)- National
opioid expert Dr. Peggy Compton visited the University
of Buffalo to discuss translational research in
opioid use disorder and
chronic pain.
People with
chronic opioid use disorders are more likely to relapse and do so sooner if they are treated in a compulsory drug detention centre rather than a voluntary drug treatment centre
using methadone maintenance therapy, according to the first study comparing the outcome
of both approaches published in The Lancet Global Health.
A team
of researchers at the University
of Colorado School
of Medicine and the VA Eastern Colorado Health Care System recently surveyed patients to understand barriers to reducing the
use of opioids to manage
chronic pain.
Paul Ross, 60, has had 13 surgeries in the past 35 years, resulting in constant
chronic pain and prescriptions for high doses
of hydromorphone, which is
used to treat severe pain that isn't controlled by other
opioid drugs.
Psychological support and new coping skills are helping patients at high risk
of developing
chronic pain and long - term, high - dose
opioid use taper their
opioids and rebuild their lives with activities that are meaningful and joyful to them.
A new, team - based, primary care model is decreasing prescription
opioid use among patients with
chronic pain by 40 percent, according to a new study out
of Boston Medical Center's Grayken Center for Addiction Medicine, which is published online ahead
of print in JAMA Internal Medicine.
The findings, published online ahead
of print in the Annals
of Internal Medicine, highlight the challenges faced by physicians to balance the known risks with potential benefits
of prescription
opioids for patients with
chronic pain and reinforces the importance
of developing tools that will help better identify and treat patients at risk for
opioid use disorders and / or overdose.
Results reveal that on average, the 13 states allowing the
use of medical marijuana had a 24.8 percent lower annual
opioid overdose mortality rate after the laws were enacted than states without the laws, indicating that the alternative treatment may be safer for patients suffering from
chronic pain related to cancer and other conditions.
Waldfogel noted that the long - term
use of opioids is not recommended for
chronic pain due to lack
of evidence
of long - term benefit and the risk
of abuse, misuse and overdose.
The safe and effective
use of opioids for the management
of chronic pain is complex.
Rates
of chronic opioid use are also higher in those with rheumatoid arthritis, particularly among younger patients and women.
The review traced the treatment
of opioid use disorder in the United States dating back to the 1930s, with particular focus beginning with the widespread prescribed
use of opioids to address symptoms
of chronic pain in the 1990s.
As for the safety
of medical marijuana as an
opioid alternative, one
of the most extensive reports to date was published late last year in the Journal
of Pain and followed about 200 patients
using cannabis for
chronic pain over 12 months.
The high prevalence and intensity
of opioid use among SSDI recipients parallels the preponderance
of musculoskeletal disorders, such as back pain — some type
of musculoskeletal condition was present in 94 percent
of chronic opioid users.
The high proportion
of SSDI recipients who are
chronic opioid users — in many, at high and very high daily doses — «is worrisome in light
of established and growing evidence that intense
opioid use to treat non-malignant [non-cancer] pain may not be effective and may confer important risk,» write Dr Nancy Elizabeth Morden and colleagues
of the Dartmouth Institute for Health Policy & Clinical Practice, Lebanon, N.H.
They urge further studies to assess the clinical outcomes
of opioid use by under - 65 disabled workers and factors associated with
chronic opioid use.
The new guide aims to prevent this kind
of new
chronic opioid use by giving detailed amounts
of hydrocodone, oxycodone, tramadol and codeine / acetaminophen in an easy - to - print chart.
Gut microbiota varies by
opioid use, circulating leptin and oxytocin in African American men with diabetes and high burden
of chronic disease — Elena Barengolts — PLOS One
Addressing
opioid prescribing during the acute care period among those patients not
using opioids has the greatest potential to reduce the number
of new
chronic opioid users and minimize unintended distribution
of prescription
opioids into communities.
There is a shortage
of high - quality evidence demonstrating the safety and effectiveness
of long - term
opioid therapy for the management
of chronic pain, and to date, no large - scale studies have assessed strategies for managing and reducing
chronic opioid use in real - world clinical settings.
The Michigan researchers examined whether
using medical cannabis for
chronic pain changed patterns
of opioid use.
Opioid drugs
used to relieve pain in postoperative and
chronic cancer patients may stimulate the growth and spread
of tumors, according to two studies and a commentary in the 2012 annual Journal Symposium issue
of Anesthesiology, the academic journal
of the American Society
of Anesthesiologists.
But I want to acknowledge what my colleagues would say, many
of them — that 25 years
of research has yet to show the evidence that long - term
opioid use is effective for
chronic pain.
A: It looks like about 60 %
of patients with
chronic pain have flairs that can be called breakthrough pain, and in the cancer population, the
use of a short - acting
opioid co-administered with a long - acting drug is the standard
of care.
Between 21 percent and 29 percent
of people who are prescribed
opioids for
chronic pain misuse them; between eight percent and 12 percent develop an
opioid use disorder.
Clinical observations
of patients with
chronic pain who require
opioid treatment support the scientific research and the adverse effects
of pain and
opioids on the endocrine — nutrition systems.1 - 9 In order to evaluate a patient's nutritional status, I
use a 72 - hour «Food and Drink Recall Diary» form with new patients with
chronic pain (see Table 3).
Opioid use may cause blood sugar levels to be very unstable and may cause hypoglycemia.5 - 7 Opioids also cause a «sugar desire effect» on opioid receptors.8, 9 Consequently, the combination of severe chronic pain and opioid treatment can cause deranged glucose metabolism in patients and a potent desire to ingest primarily sugars and starches, with little protein or fat i
Opioid use may cause blood sugar levels to be very unstable and may cause hypoglycemia.5 - 7
Opioids also cause a «sugar desire effect» on
opioid receptors.8, 9 Consequently, the combination of severe chronic pain and opioid treatment can cause deranged glucose metabolism in patients and a potent desire to ingest primarily sugars and starches, with little protein or fat i
opioid receptors.8, 9 Consequently, the combination
of severe
chronic pain and
opioid treatment can cause deranged glucose metabolism in patients and a potent desire to ingest primarily sugars and starches, with little protein or fat i
opioid treatment can cause deranged glucose metabolism in patients and a potent desire to ingest primarily sugars and starches, with little protein or fat intake.
Constant rate infusion pain medications during and after surgery, ketamine drips for
chronic pain, widespread
use of local anesthesia, including soaker catheters after large surgeries, testicular blocks, line blocks and more aggressive
opioid and gabapentin
use are all things Gwen helped bring to the table.
For surgeries as well as for acute and
chronic conditions we
use all our available and safe resources, including
opioids, local anesthetics, NSAIDs (non-steroidal medications) and oral and injectable analgesics for the complete comfort
of your pet.